We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
11
4 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
1918
No Longer Available
2
18.2%
Not yet recruiting
4
36.4%
Recruiting
5
45.5%
No approval data available
- The University of Texas at Arlington is creating a novel Ph.D. program where each doctoral student becomes a domain expert in a single rare disease, spanning from lab research to clinical trials and treatment. - The initiative, led by Professor Dennis Lal, builds on UTA's collaboration with Cook Children's Health Care System and was shaped by input from 16 family foundations at a rare disease symposium. - The FamilieSCN2A Foundation has already committed to sponsoring a disease-anchored Ph.D. student, embedding dedicated expertise within the Cook–UTA ecosystem. - The program aims to address the "diagnostic odyssey" and fragmented care barriers that rare disease patients face, connecting patient communities, specialty clinics, research labs, and industry partners.